Alkermes plc. Treasury Stock, Common, Value
Alkermes plc. (ALKS) had Treasury Stock, Common, Value of $502.52 million as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:TreasuryStockCommonValue · last filed 2026-07-28
- 2026-06-30: Treasury Stock, Common, Value $502.52M.
- 2026-03-31: Treasury Stock, Common, Value $501.43M.
- 2025-12-31: Treasury Stock, Common, Value $450.29M.
- 2025-09-30: Treasury Stock, Common, Value $450.02M.
| Period end | Treasury Stock, Common, Value |
|---|---|
| 2026-06-30 | $502.52M 10-Q · filed 2026-07-28 |
| 2026-03-31 | $501.43M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $450.29M 10-Q · filed 2026-07-28 |
| 2025-09-30 | $450.02M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $449.71M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $448.04M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $419.25M 10-K · filed 2026-02-25 |
| 2024-09-30 | $418.91M 10-Q · filed 2024-10-24 |
| 2024-06-30 | $303.02M 10-Q · filed 2024-07-24 |
| 2024-03-31 | $217.69M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $189.34M 10-K · filed 2025-02-12 |
| 2023-09-30 | $186.94M 10-Q · filed 2023-10-25 |
| 2023-06-30 | $186.15M 10-Q · filed 2023-07-26 |
| 2023-03-31 | $185.61M 10-Q · filed 2023-04-26 |
| 2022-12-31 | $160.86M 10-K · filed 2024-02-21 |
| 2022-09-30 | $160.56M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $160.24M 10-Q · filed 2022-07-27 |
| 2022-03-31 | $159.73M 10-Q · filed 2022-04-27 |
| 2021-12-31 | $142.66M 10-K · filed 2023-02-16 |
| 2021-09-30 | $139.72M 10-Q · filed 2021-10-27 |
| 2021-06-30 | $137.21M 10-Q · filed 2021-07-28 |
| 2021-03-31 | $136.50M 10-Q · filed 2021-04-28 |
| 2020-12-31 | $126.09M 10-K · filed 2022-02-16 |
| 2020-09-30 | $125.99M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $125.79M 10-Q · filed 2020-07-29 |
| 2020-03-31 | $125.67M 10-Q · filed 2020-04-29 |
| 2019-12-31 | $118.39M 10-K · filed 2021-02-11 |
| 2019-09-30 | $118.30M 10-Q · filed 2019-10-23 |
| 2019-06-30 | $118.14M 10-Q · filed 2019-07-25 |
| 2019-03-31 | $117.95M 10-Q · filed 2019-04-25 |
| 2018-12-31 | $108.97M 10-K · filed 2020-02-13 |
| 2018-09-30 | $105.13M 10-Q · filed 2018-10-23 |
| 2018-06-30 | $105.09M 10-Q · filed 2018-07-26 |
| 2018-03-31 | $105.07M 10-Q · filed 2018-04-26 |
| 2017-12-31 | $89.35M 10-K · filed 2019-02-15 |
| 2017-09-30 | $89.31M 10-Q · filed 2017-10-26 |
| 2017-06-30 | $89.22M 10-Q · filed 2017-07-27 |
| 2017-03-31 | $85.83M 10-Q · filed 2017-04-27 |
| 2016-12-31 | $72.64M 10-K · filed 2018-02-16 |
| 2016-09-30 | $67.25M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $67.09M 10-Q · filed 2016-07-28 |
| 2015-12-31 | $58.66M 10-K · filed 2017-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |